MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clinre.2024.102355

Медицинская библиотека · Clinics and research in hepatology and gastroenterology · 2024

The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.

Leideck Paul, Nkontchou Gisèle, Elkrief Laure, Erard Domitille, d'Alteroche Louis, Radenne Sylvie, Billioud Claire, Meszaros Magdalena, Regnault David, Pageaux Georges-Philippe, Hilleret Marie-Noëlle, Tripon Simona, Guillaud Olivier, Ollivier-Hourmand Isabelle, Ganne-Carrié Nathalie, Dumortier Jérôme

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Partial splenic embolization (PSE) has been proposed to treat the consequences of hypersplenism in the context of portal hypertension, especially thrombocytopenia. However, a high morbidity/mortality rate has made this technique unpopular. We conducted a multicenter retrospective nationwide French study to reevaluate efficacy and tolerance.

METHODS

All consecutive patients who underwent PSE for hypersplenism and portal hypertension in 7 tertiary liver centers between 1998 and 2023 were included.

RESULTS

The study population consisted of 91 procedures in 90 patients, with a median age of 55.5 years [range 18-83]. The main cause of portal hypertension was cirrhosis (84.6 %). The main indications for PSE were (1) an indication of medical treatment or radiological/surgical procedure in the context a severe thrombocytopenia (59.3 %), (2) a chronic hemorrhagic disorder associated with a severe thrombocytopenia (18.7 %), and (3) a chronic pain associated with a major splenomegaly (9.9 %). PSE was associated with a transjugular intrahepatic portosystemic shunt in 20 cases. Median follow-up after PSE was 41.9 months [0.5-270.5]. Platelet count increased from a median of 48.0 G/L [IQR 37.0; 60.0] to 100.0 G/L [75.0; 148]. Forty-eight patients (52.7 %) had complications after PSE; 25 cases were considered severe (including 7 deaths). A Child-Pugh B-C score (p < 0.02) was significantly associated with all complications, a history of portal vein thrombosis (p < 0.01), and the absence of prophylactic antibiotherapy (p < 0.05) with severe complications.

CONCLUSION

Our results strongly confirm that PSE is very effective, for a long time, although a quarter of the patients experienced severe complications. Improved patient selection (exclusion of patients with portal vein thrombosis and decompensated cirrhosis) and systematic prophylactic antibiotherapy could reduce morbidity and early mortality in the future.

Для цитирования: Leideck Paul, Nkontchou Gisèle, Elkrief Laure, Erard Domitille, d'Alteroche Louis, Radenne Sylvie, Billioud Claire, Meszaros Magdalena, Regnault David, Pageaux Georges-Philippe, Hilleret Marie-Noëlle, Tripon Simona, Guillaud Olivier, Ollivier-Hourmand Isabelle, Ganne-Carrié Nathalie, Dumortier Jérôme. The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.. Clinics and research in hepatology and gastroenterology. 2024. DOI: 10.1016/j.clinre.2024.102355.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.